R. Kebudi Et Al. , "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN," 54th Congress of the International Society of Paediatric Oncology (SIOP) , Barcelona, Spain, pp.61, 2022
Kebudi, R. Et Al. 2022. IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN. 54th Congress of the International Society of Paediatric Oncology (SIOP) , (Barcelona, Spain), 61.
Kebudi, R., Büyükkapu Bay, S., Yıldırım, Ü. M., & Salduz, A., (2022). IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN . 54th Congress of the International Society of Paediatric Oncology (SIOP) (pp.61). Barcelona, Spain
Kebudi, Rejin Et Al. "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN," 54th Congress of the International Society of Paediatric Oncology (SIOP), Barcelona, Spain, 2022
Kebudi, Rejin Et Al. "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN." 54th Congress of the International Society of Paediatric Oncology (SIOP) , Barcelona, Spain, pp.61, 2022
Kebudi, R. Et Al. (2022) . "IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN." 54th Congress of the International Society of Paediatric Oncology (SIOP) , Barcelona, Spain, p.61.
@conferencepaper{conferencepaper, author={Rejin KEBUDİ Et Al. }, title={IMPACT OF ADDING MIFAMURTIDE TO A NON-METHOTREXATE THREE-DRUG CHEMOTHERAPY REGIMEN}, congress name={54th Congress of the International Society of Paediatric Oncology (SIOP)}, city={Barcelona}, country={Spain}, year={2022}, pages={61} }